Literature DB >> 25187064

In vivo activation and functions of the protease factor XII.

Jenny Björkqvist, Katrin F Nickel, Evi Stavrou, Thomas Renné1.   

Abstract

Combinations of proinflammatory and procoagulant reactions are the unifying principle for a variety of disorders affecting the cardiovascular system. Factor XII (FXII, Hageman factor) is a plasma protease that initiates the contact system. The biochemistry of the contact system in vitro is well understood; however, its in vivo functions are just beginning to emerge. The current review concentrates on activators and functions of the FXII-driven contact system in vivo. Elucidating its physiologic activities offers the exciting opportunity to develop strategies for the safe interference with both thrombotic and inflammatory diseases.

Entities:  

Keywords:  Coagulation factors; contact phase; proteases

Mesh:

Substances:

Year:  2014        PMID: 25187064     DOI: 10.1160/TH14-04-0311

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  20 in total

1.  Inhibition of factor XIIa, a new approach in management of thrombosis.

Authors:  Akbar Dorgalaleh; Maryam Sadat Hosseini; Rashideh Naseri Mobaraki; Shaban Alizadeh; Soudabeh Hosseini; Shadi Tabibian; Morteza Shamsizadeh; Esmaeil Saneei Moghaddam; Sohila Khosravi; Aziz Rahimizadeh
Journal:  Ann Transl Med       Date:  2015-05

Review 2.  The initiation and effects of plasma contact activation: an overview.

Authors:  Lisha Lin; Mingyi Wu; Jinhua Zhao
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

3.  Limited role of kininogen in the host response during gram-negative pneumonia-derived sepsis.

Authors:  Chao Ding; Cornelis van 't Veer; Joris J T H Roelofs; Meenal Shukla; Keith R McCrae; Alexey S Revenko; Jeff Crosby; Tom van der Poll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-09       Impact factor: 5.464

4.  Serum stimulation of CCR7 chemotaxis due to coagulation factor XIIa-dependent production of high-molecular-weight kininogen domain 5.

Authors:  Manish P Ponda; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

5.  FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.

Authors:  Shu Zhu; Richard J Travers; James H Morrissey; Scott L Diamond
Journal:  Blood       Date:  2015-07-01       Impact factor: 22.113

6.  Modeling and dynamical analysis of the full-length structure of factor XII with zinc.

Authors:  Evren Kılınç; Ahmet Can Timucin; Suleyman Selim Cinaroglu; Emel Timucin
Journal:  J Mol Model       Date:  2022-04-25       Impact factor: 1.810

7.  Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke.

Authors:  Zhiye Zhang; Chuanbin Shen; Mingqian Fang; Yajun Han; Chengbo Long; Weihui Liu; Min Yang; Ming Liu; Dengdeng Zhang; Qiqi Cao; Xue Chen; Yaqun Fang; Qiumin Lu; Zongliu Hou; Yaxiong Li; Zhenze Liu; Xi Lei; Heyu Ni; Ren Lai
Journal:  Cell Mol Life Sci       Date:  2022-04-13       Impact factor: 9.261

8.  Surface dependent contact activation of factor XII and blood plasma coagulation induced by mixed thiol surfaces.

Authors:  James W Bauer; Li-Chong Xu; Erwin A Vogler; Christopher A Siedlecki
Journal:  Biointerphases       Date:  2017-05-17       Impact factor: 2.456

9.  A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.

Authors:  Yasin Kokoye; Ivan Ivanov; Qiufang Cheng; Anton Matafonov; S Kent Dickeson; Shauna Mason; Daniel J Sexton; Thomas Renné; Keith McCrae; Edward P Feener; David Gailani
Journal:  Thromb Res       Date:  2016-02-18       Impact factor: 3.944

Review 10.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.